Alivus Life Sciences P/E Ratio
Current P/E Ratio
22.79
Moderate Valuation
High - Growth expectations or overvalued
Alivus Life Sciences (ALIVUS) P/E ratio is 22.79 (Moderate), EPS (TTM) ₹45.99, current price ₹1070.30 on NSE — High - Growth expectations or overvalued. For live price, revenue and the complete fundamental profile, see ALIVUS share price.
Current Valuation Metrics
P/E Ratio
22.79
Current Price
₹1070.30
EPS (TTM)
₹45.99
Exchange
NSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
49.19
Sector Median
29.34
Sector Rank
#11 of 193
Sector Percentile
5.7%
ALIVUS P/E Ratio — Valuation Signal & Historical Context
Alivus Life Sciences P/E 22.79 — signal: Overvalued. Analyse ALIVUS promoter holding to track promoter, FII and institutional holdings.
- Trading at discount to sector average PE of 49.19
ALIVUS vs Healthcare Peers — P/E Ratio Comparison
Alivus Life Sciences P/E 22.79 vs Healthcare average 49.19, median 29.34 — range 0.97–869.57.
Sector Average
49.19
Sector Median
29.34
Lowest P/E
0.97
Highest P/E
869.57
Companies
193
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Welcure Drugs & Pharmace… | WELCURE | 0.97 | ₹36 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Phaarmasia | PHRMASI | 3.13 | ₹53 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.39 | ₹7,561 | Low |
| Ind Swift Laboratories | INDSWFTLAB | 4.61 | ₹1,146 | Low |
| Amwill Health Care | AMWILL | 6.04 | ₹65 | Low |
| Mono Pharmacare | MONOPHARMA | 6.85 | ₹20 | Low |
| Medicamen Organics | MEDIORG | 6.94 | ₹28 | Low |
| Brooks Laboratories | BROOKS | 7.38 | ₹166 | Low |
| Shelter Pharma | SHELTER | 7.4 | ₹54 | Low |